Randomized phase II study of S-1 and concurrent radiotherapy with versus without induction chemotherapy of gemcitabine for locally advanced pancreatic cancer (JCOG1106)

被引：1
|
作者：
Fukutomi, Akira
Mizusawa, Junki
Katayama, Hiroshi
Nakamura, Satoaki
Ito, Yoshinori
Hiraoka, Nobuyoshi
Ioka, Tatsuya
Ueno, Makoto
Ikeda, Masafumi
Sugimori, Kazuya
Shimizu, Kyoko
Okusaka, Takuji
Ozaka, Masato
Yanagimoto, Hiroaki
Nakamori, Shoji
Azuma, Takeshi
Hosokawa, Ayumu
Sata, Naohiro
Mine, Tetsuya
Furuse, Junji
机构：
[1] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan
[2] Natl Canc Ctr, Clin Oncol Grp, Ctr Data, Ctr Res Adm & Support, Tokyo 104, Japan
[3] Kyoto Prefectural Univ Med, Dept Radiol, Kyoto, Japan
[4] Natl Canc Ctr, Dept Radiat Oncol, Tokyo, Japan
[5] Natl Canc Ctr, Div Pathol & Clin Labs, Tokyo, Japan
[6] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan
[7] Kanagawa Canc Ctr, Div Hepatobiliary & Pancreat Oncol, Yokohama, Kanagawa 2410815, Japan
[8] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan
[9] Yokohama City Univ, Gastroenterol Ctr, Med Ctr, Yokohama, Kanagawa 232, Japan
[10] Tokyo Womens Med Univ, Inst Gastroenterol, Tokyo, Japan
[11] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan
[12] Japanese Fdn Canc Res, Canc Inst Hosp, Hepatobiliary & Pancreat Div, Tokyo, Japan
[13] Kansai Med Univ, Hirakata Hosp, Dept Surg, Hirakata, Osaka, Japan
[14] Osaka Natl Hosp, Dept Hepatobiliary & Pancreat Surg, Osaka, Japan
[15] Kobe Univ, Dept Internal Med, Sch Med, Div Gastroenterol, Kobe, Hyogo 657, Japan
[16] Toyama Univ, Dept Gastroenterol & Hematol, Fac Med, Toyama 930, Japan
[17] Jichi Med Univ, Sch Med, Dept Surg, Shimotsuke, Japan
[18] Tokai Univ, Sch Med, Dept Gastroenterol & Hepatol, Isehara, Kanagawa 25911, Japan
[19] Kyorin Univ, Sch Med, Dept Med Oncol, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.4116
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4116
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer
    T Okusaka
    Y Ito
    H Ueno
    M Ikeda
    Y Takezako
    C Morizane
    Y Kagami
    H Ikeda
    British Journal of Cancer, 2004, 91 : 673 - 677
  • [32] Effect of systemic inflammatory response on induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancer: an exploratory subgroup analysis on systemic inflammatory response in JCOG1106
    Mizuno, Nobumasa
    Ioka, Tatsuya
    Ogawa, Gakuto
    Nakamura, Satoaki
    Hiraoka, Nobuyoshi
    Ito, Yoshinori
    Katayama, Hiroshi
    Takada, Ryoji
    Kobayashi, Satoshi
    Ikeda, Masafumi
    Miwa, Haruo
    Okano, Naohiro
    Kuramochi, Hidekazu
    Sekimoto, Mitsugu
    Okusaka, Takuji
    Ozaka, Masato
    Todaka, Akiko
    Gotoh, Kunihito
    Tobimatsu, Kazutoshi
    Yamaguchi, Hironori
    Nakagohri, Toshio
    Kajiura, Shinya
    Sudo, Kentaro
    Okamura, Keiya
    Shimizu, Satoshi
    Shirakawa, Hirofumi
    Kato, Naoya
    Sano, Keiji
    Iwai, Tomohisa
    Fujimori, Nao
    Ueno, Makoto
    Ishii, Hiroshi
    Furuse, Junji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (08) : 704 - 713
  • [33] Induction Gemcitabine Plus Concurrent Gemcitabine and Radiotherapy for Locally Advanced Unresectable or Resected Pancreatic Cancer
    Youl, M.
    Hashem, S.
    Brade, A.
    Cummings, B.
    Dawson, L. A.
    Gallinger, S.
    Hedley, D.
    Jiang, H.
    Kim, J.
    Krzyzanowska, M. K.
    Ringash, J.
    Wong, R.
    Brierley, J.
    CLINICAL ONCOLOGY, 2014, 26 (04) : 203 - 209
  • [34] Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: A Japan Clinical Oncology Group trial (JCOG 0805)
    Morizane, Chigusa
    Okusaka, Takuji
    Mizusawa, Junki
    Takashima, Atsuo
    Ueno, Makoto
    Ikeda, Masafumi
    Hamamoto, Yasuo
    Ishii, Hiroshi
    Boku, Narikazu
    Furuse, Junji
    CANCER SCIENCE, 2013, 104 (09): : 1211 - 1216
  • [35] Concurrent Chemoradiotherapy with or without Induction Chemotherapy versus Chemotherapy Alone in Patients with Locally Advanced Pancreatic Cancer
    Huang, Wen-Kuan
    Ku, Yung-Chia
    Tsang, Ngan-Ming
    Hsu, Hung-Chih
    Shen, Wen-Chi
    Chou, Wen-Chi
    Yang, Tsain-Sheng
    Chen, Jen-Shi
    ANTICANCER RESEARCH, 2014, 34 (11) : 6755 - 6761
  • [36] THE PROSPECTIVE STUDY OF S-1+GEMCITABINE AND CONCURRENT RADIOTHERAPY FOR UNRESECTABLE LOCALLY ADVANCED PANCREATIC CANCER
    Kimura, Tetsuo
    Goji, Takahiro
    Miyoshi, Jinsei
    Fujino, Yasuteru
    Kitamura, Shinji
    Sato, Momoko
    Kimura, Masako
    Miyamoto, Hiroshi
    Muguruma, Naoki
    Takayama, Tetsuji
    ANNALS OF ONCOLOGY, 2014, 25
  • [37] A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer
    Ueno, M.
    Okusaka, T.
    Omuro, Y.
    Isayama, H.
    Fukutomi, A.
    Ikeda, M.
    Mizuno, N.
    Fukuzawa, K.
    Furukawa, M.
    Iguchi, H.
    Sugimori, K.
    Furuse, J.
    Shimada, K.
    Ioka, T.
    Nakamori, S.
    Baba, H.
    Komatsu, Y.
    Takeuchi, M.
    Hyodo, I.
    Boku, N.
    ANNALS OF ONCOLOGY, 2016, 27 (03) : 502 - 508
  • [38] A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer
    Han, Boram
    Kim, Bum Jun
    Kim, Hyeong Su
    Choi, Dae Ro
    Shim, Byoung Yong
    Lee, Kyung Hee
    Kim, Jin Won
    Kim, Jung Han
    Song, Hunho
    Kim, Jong Hyeok
    Park, Choong Kee
    Lee, Jung Woo
    Kim, Min-Jeong
    Zang, Dae Young
    JOURNAL OF CANCER, 2021, 12 (03): : 912 - 917
  • [39] Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer
    Kentaro Sudo
    Takeshi Ishihara
    Nobuto Hirata
    Fumiaki Ozawa
    Tadashi Ohshima
    Ryosaku Azemoto
    Kenji Shimura
    Takeshi Nihei
    Takayoshi Nishino
    Akihiko Nakagawa
    Kazuyoshi Nakamura
    Taro Hara
    Motohisa Tada
    Rintaro Mikata
    Katsunobu Tawada
    Osamu Yokosuka
    So Nakaji
    Taketo Yamaguchi
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 389 - 396
  • [40] Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer
    Sudo, Kentaro
    Ishihara, Takeshi
    Hirata, Nobuto
    Ozawa, Fumiaki
    Ohshima, Tadashi
    Azemoto, Ryosaku
    Shimura, Kenji
    Nihei, Takeshi
    Nishino, Takayoshi
    Nakagawa, Akihiko
    Nakamura, Kazuyoshi
    Hara, Taro
    Tada, Motohisa
    Mikata, Rintaro
    Tawada, Katsunobu
    Yokosuka, Osamu
    Nakaji, So
    Yamaguchi, Taketo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (02) : 389 - 396
12345